215 related articles for article (PubMed ID: 18523453)
1. Interstitial 22q13 deletions: genes other than SHANK3 have major effects on cognitive and language development.
Wilson HL; Crolla JA; Walker D; Artifoni L; Dallapiccola B; Takano T; Vasudevan P; Huang S; Maloney V; Yobb T; Quarrell O; McDermid HE
Eur J Hum Genet; 2008 Nov; 16(11):1301-10. PubMed ID: 18523453
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterisation of patients with subtelomeric 22q abnormalities using chromosome specific array-based comparative genomic hybridisation.
Koolen DA; Reardon W; Rosser EM; Lacombe D; Hurst JA; Law CJ; Bongers EM; van Ravenswaaij-Arts CM; Leisink MA; van Kessel AG; Veltman JA; de Vries BB
Eur J Hum Genet; 2005 Sep; 13(9):1019-24. PubMed ID: 15986041
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 22q13.3 deletion syndrome with a de novo interstitial 22q13.3 cryptic deletion disrupting SHANK3.
Delahaye A; Toutain A; Aboura A; Dupont C; Tabet AC; Benzacken B; Elion J; Verloes A; Pipiras E; Drunat S
Eur J Med Genet; 2009; 52(5):328-32. PubMed ID: 19454329
[TBL] [Abstract][Full Text] [Related]
4. Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome).
Sarasua SM; Dwivedi A; Boccuto L; Rollins JD; Chen CF; Rogers RC; Phelan K; DuPont BR; Collins JS
J Med Genet; 2011 Nov; 48(11):761-6. PubMed ID: 21984749
[TBL] [Abstract][Full Text] [Related]
5. FISH-mapping of a 100-kb terminal 22q13 deletion.
Anderlid BM; Schoumans J; Annerén G; Tapia-Paez I; Dumanski J; Blennow E; Nordenskjöld M
Hum Genet; 2002 May; 110(5):439-43. PubMed ID: 12073014
[TBL] [Abstract][Full Text] [Related]
6. Interstitial 22q13 deletions not involving SHANK3 gene: a new contiguous gene syndrome.
Disciglio V; Lo Rizzo C; Mencarelli MA; Mucciolo M; Marozza A; Di Marco C; Massarelli A; Canocchi V; Baldassarri M; Ndoni E; Frullanti E; Amabile S; Anderlid BM; Metcalfe K; Le Caignec C; David A; Fryer A; Boute O; Joris A; Greco D; Pecile V; Battini R; Novelli A; Fichera M; Romano C; Mari F; Renieri A
Am J Med Genet A; 2014 Jul; 164A(7):1666-76. PubMed ID: 24700646
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms.
Wilson HL; Wong AC; Shaw SR; Tse WY; Stapleton GA; Phelan MC; Hu S; Marshall J; McDermid HE
J Med Genet; 2003 Aug; 40(8):575-84. PubMed ID: 12920066
[TBL] [Abstract][Full Text] [Related]
8. Microdeletion at chromosome 4q21 defines a new emerging syndrome with marked growth restriction, mental retardation and absent or severely delayed speech.
Bonnet C; Andrieux J; Béri-Dexheimer M; Leheup B; Boute O; Manouvrier S; Delobel B; Copin H; Receveur A; Mathieu M; Thiriez G; Le Caignec C; David A; de Blois MC; Malan V; Philippe A; Cormier-Daire V; Colleaux L; Flori E; Dollfus H; Pelletier V; Thauvin-Robinet C; Masurel-Paulet A; Faivre L; Tardieu M; Bahi-Buisson N; Callier P; Mugneret F; Edery P; Jonveaux P; Sanlaville D
J Med Genet; 2010 Jun; 47(6):377-84. PubMed ID: 20522426
[TBL] [Abstract][Full Text] [Related]
9. A 797 kb de novo deletion of 18q21.31 in a patient with speech delay, mental retardation, sleeping problems, facial dysmorphism, and feet anomalies.
van Diepen MM; Gijsbers AC; Bosch CA; Oudesluys-Murphy AM; Ruivenkamp CA; Bijlsma EK
Eur J Med Genet; 2011; 54(1):86-8. PubMed ID: 20870045
[TBL] [Abstract][Full Text] [Related]
10. 22q13.3 deletion syndrome: a recognizable malformation syndrome associated with marked speech and language delay.
Cusmano-Ozog K; Manning MA; Hoyme HE
Am J Med Genet C Semin Med Genet; 2007 Nov; 145C(4):393-8. PubMed ID: 17926345
[TBL] [Abstract][Full Text] [Related]
11. A patient with the classic features of Phelan-McDermid syndrome and a high immunoglobulin E level caused by a cryptic interstitial 0.72-Mb deletion in the 22q13.2 region.
Simenson K; Õiglane-Shlik E; Teek R; Kuuse K; Õunap K
Am J Med Genet A; 2014 Mar; 164A(3):806-9. PubMed ID: 24375995
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychiatry and deletions of 18q; case report and diagnostic considerations.
Verhoeven WM; Feenstra I; Van Ravenswaay-Arts C; Egger JI; Van Beurden JJ; Tuinier S
Genet Couns; 2006; 17(3):307-13. PubMed ID: 17100199
[TBL] [Abstract][Full Text] [Related]
13. Characterization of an interstitial deletion 6q13-q14.1 in a female with mild mental retardation, language delay and minor dysmorphisms.
Lespinasse J; Gimelli S; Béna F; Antonarakis SE; Ansermet F; Paoloni-Giacobino A
Eur J Med Genet; 2009; 52(1):49-52. PubMed ID: 18992376
[TBL] [Abstract][Full Text] [Related]
14. Neurobehavioral profile and brain imaging study of the 22q13.3 deletion syndrome in childhood.
Philippe A; Boddaert N; Vaivre-Douret L; Robel L; Danon-Boileau L; Malan V; de Blois MC; Heron D; Colleaux L; Golse B; Zilbovicius M; Munnich A
Pediatrics; 2008 Aug; 122(2):e376-82. PubMed ID: 18625665
[TBL] [Abstract][Full Text] [Related]
15. A 29 Mainland Chinese cohort of patients with Phelan-McDermid syndrome: genotype-phenotype correlations and the role of SHANK3 haploinsufficiency in the important phenotypes.
Xu N; Lv H; Yang T; Du X; Sun Y; Xiao B; Fan Y; Luo X; Zhan Y; Wang L; Li F; Yu Y
Orphanet J Rare Dis; 2020 Nov; 15(1):335. PubMed ID: 33256793
[TBL] [Abstract][Full Text] [Related]
16. Deletions of VCX-A and NLGN4: a variable phenotype including normal intellect.
Macarov M; Zeigler M; Newman JP; Strich D; Sury V; Tennenbaum A; Meiner V
J Intellect Disabil Res; 2007 May; 51(Pt 5):329-33. PubMed ID: 17391250
[TBL] [Abstract][Full Text] [Related]
17. No evidence for submicroscopic 22qter deletions in patients with features suggestive for Angelman syndrome.
de Vries BB; Tyson J; Winter RM; Malcolm S
Am J Med Genet; 2002 Apr; 109(2):117-20. PubMed ID: 11977159
[TBL] [Abstract][Full Text] [Related]
18. Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial.
Schmidt H; Kern W; Giese R; Hallschmid M; Enders A
J Med Genet; 2009 Apr; 46(4):217-22. PubMed ID: 18948358
[TBL] [Abstract][Full Text] [Related]
19. Four patients with speech delay, seizures and variable corpus callosum thickness sharing a 0.440 Mb deletion in region 1q44 containing the HNRPU gene.
Caliebe A; Kroes HY; van der Smagt JJ; Martin-Subero JI; Tönnies H; van 't Slot R; Nievelstein RA; Muhle H; Stephani U; Alfke K; Stefanova I; Hellenbroich Y; Gillessen-Kaesbach G; Hochstenbach R; Siebert R; Poot M
Eur J Med Genet; 2010; 53(4):179-85. PubMed ID: 20382278
[TBL] [Abstract][Full Text] [Related]
20. A de novo 7.9 Mb deletion in 22q13.2→qter in a boy with autistic features, epilepsy, developmental delay, atopic dermatitis and abnormal immunological findings.
Chen CP; Lin SP; Chern SR; Tsai FJ; Wu PC; Lee CC; Chen YT; Chen WL; Wang W
Eur J Med Genet; 2010; 53(5):329-32. PubMed ID: 20541044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
